Universitätsklinikum Essen

Proficiency Test PD-L1 Expression in Squamous Cell Carcinomas of the Head and Neck (HNSCC) (2021) Joehrens K, Baretton G, Schildhaus HU, Agaimy A, Scheel A, Schwammborn K, Laenger F, et al. Journal article, Editorial Loss-of-function mutations of bcor are an independent marker of adverse outcomes in intensively treated patients with acute myeloid leukemia (2021) Eckardt JN, Stasik S, Kramer M, Röllig C, Krämer A, Scholl S, Hochhaus A, et al. Journal article Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classification (2021) Höhn J, Krieghoff-Henning E, Jutzi TB, von Kalle C, Utikal JS, Meier F, Gellrich FF, et al. Journal article Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response (2021) Dimitriou F, Zaremba A, Allayous C, Kähler KC, Gerard CL, Festino L, Schäfer S, et al. Journal article Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition (2021) Knispel S, Gassenmaier M, Menzies AM, Loquai C, Johnson DB, Franklin C, Gutzmer R, et al. Journal article Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease (2021) Zhang Y, Shen L, Dreißigacker K, Zhu H, Trinh MT, Meng X, Tran Manh C, et al. Journal article A vaccine targeting mutant IDH1 in newly diagnosed glioma (2021) Platten M, Bunse L, Wick A, Bunse T, Le Cornet L, Harting I, Sahm F, et al. Journal article Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives (2021) Zoellner SK, Amatruda JE, Bauer S, Collaud S, De Alava E, Dubois SG, Hardes J, et al. Journal article, Review article Hematological immune related adverse events after treatment with immune checkpoint inhibitors (2021) Kramer R, Zaremba A, Moreira A, Ugurel S, Johnson DB, Hassel JC, Salzmann M, et al. Journal article Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma (2021) Dighe SG, Chen J, Yan L, He Q, Gharahkhani P, Onstad L, Levine DM, et al. Journal article